Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren's Syndrome
Clinical trial NCT04496960 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04496960
- Sponsor
- National Institute of Dental and Craniofacial Research (NIDCR)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-18
- Primary completion
- 2025-01-14
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.